Antibacterial Wet Wipes: Is Your Claim Substantiation Robust Enough?
Antibacterial wet wipes continue to grow across personal hygiene, and on-the-go cleansing applications. However, alongside this growth, manufacturers are facing increasing scrutiny regarding the scientific evidence supporting product claims.
Statements such as "Eliminates 99.9% of bacteria," "Long-lasting protection," and "Dermatologically tested" are frequently used across the market. However, retailers, brand owners, regulatory teams and customers increasingly expect these claims to be supported by documented data and appropriate testing.
Demonstrating antibacterial efficacy requires robust microbiological studies performed using relevant test methods and microorganisms. Claims related to residual or long-lasting activity may require additional evidence to support the duration of the claimed effect. Likewise, skin compatibility assessments are often expected to support dermatological claims, particularly for products intended for frequent use or sensitive populations.
The increasing focus on claim substantiation is also reinforcing the importance of product claims, as they can be a key factor in determining product classification and the applicable regulatory framework. Manufacturers should therefore carefully assess both claims and intended use, and ensure that robust supporting documentation is maintained throughout the product lifecycle.
At Eurofins Cosmetics & Personal Care, we support manufacturers with:
- Antibacterial efficacy testing
- Microbiological performance studies
- Dermatological and skin compatibility assessments
- Claim substantiation strategies
- Scientific and regulatory support
As expectations for technical documentation continue to increase, a robust substantiation package remains a key element in supporting antibacterial wet wipe claims throughout product development and commercialisation.